Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors.

Publication ,  Journal Article
Shpall, EJ
Published in: J Hematother
August 1997

We believe the proposed model is appropriate to our current state of knowledge and recognize that FDA regulations will evolved as the field evolves. We thank you for the opportunity to work with FDA as its regulatory strategy is developed in the near future.

Duke Scholars

Published In

J Hematother

DOI

ISSN

1061-6128

Publication Date

August 1997

Volume

6

Issue

4

Start / End Page

287 / 289

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Quality Assurance, Health Care
  • Immunology
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Developmental Biology
  • Cytomegalovirus Infections
  • Blood Donors
  • Accreditation
 

Citation

Published In

J Hematother

DOI

ISSN

1061-6128

Publication Date

August 1997

Volume

6

Issue

4

Start / End Page

287 / 289

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Quality Assurance, Health Care
  • Immunology
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Developmental Biology
  • Cytomegalovirus Infections
  • Blood Donors
  • Accreditation